Elizabeth McFarland, MD
Pediatric Infectious Diseases
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave, Aurora, CO 80045720-777-1234
Provider Expertise
Clinical Interest for Patients
I am interested in pediatric infectious diseases, particularly pediatric and perinatal HIV Infection.
Specialties
- Pediatric Infectious Diseases ( 1992 , 2008 )
- Pediatrics ( 1990 , 2014 )
Conditions & Treatments
-
Kawasaki Disease
-
Immune System
AIDS, AIDS / HIV Disease, AIDS Immunization
-
Symptoms and Manifestations
Fever
-
Infections
Bacterial, Fungal, Influenza, Pneumonia, Viral
Education & Training
Medical Schools
MD, Duke University School of Medicine (1985)
Undergraduate Schools
BS, Northwestern University (IL) (1981)
Internships
University of Colorado (University Hospital) Program (1986)
Residency Program
University of Colorado (University Hospital) Program (1988)
Fellowships
University of Colorado (University Hospital) Program (1992)
Professional Memberships
Pediatric Infectious Disease Society, Member
Society of Pediatric Research , Member
Research & Grants
Research Interests for Patients
I am studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. I develop immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and have chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. I am a frequently invited speaker at local, national, and international events.
information for referring providers
Referral Contact Phone
(720) 777-6981
Clinical Interests for Referring Providers
I am interested in pediatric infectious diseases, particularly pediatric and perinatal HIV Infection.
Research Interest for Referring Providers
Dr. McFarland is studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. Dr. McFarland develops immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and has chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. She is a frequently invited speaker at local, national, and international events.